Maureen M. Jonas

14.7k total citations · 2 hit papers
127 papers, 8.2k citations indexed

About

Maureen M. Jonas is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Maureen M. Jonas has authored 127 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hepatology, 86 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Maureen M. Jonas's work include Liver Disease Diagnosis and Treatment (68 papers), Hepatitis C virus research (61 papers) and Hepatitis B Virus Studies (58 papers). Maureen M. Jonas is often cited by papers focused on Liver Disease Diagnosis and Treatment (68 papers), Hepatitis C virus research (61 papers) and Hepatitis B Virus Studies (58 papers). Maureen M. Jonas collaborates with scholars based in United States, United Kingdom and Canada. Maureen M. Jonas's co-authors include Jessica Hwang, Natalie Bzowej, Norah A. Terrault, Kyong‐Mi Chang, Brian J. McMahon, John B. Wong, Robert S. Brown, Anna S. Lok, M. Hassan Murad and Antonio R. Pérez‐Atayde and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Maureen M. Jonas

124 papers receiving 8.0k citations

Hit Papers

Update on prevention, diagnosis, and treatment of chronic... 2015 2026 2018 2022 2018 2015 500 1000 1.5k 2.0k 2.5k

Peers

Maureen M. Jonas
Lennox J. Jeffers United States
Paul J. Pockros United States
Henry C. Bodenheimer United States
James Fung Hong Kong
Kosh Agarwal United Kingdom
Maureen M. Jonas
Citations per year, relative to Maureen M. Jonas Maureen M. Jonas (= 1×) peers Alessandra Mangia

Countries citing papers authored by Maureen M. Jonas

Since Specialization
Citations

This map shows the geographic impact of Maureen M. Jonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen M. Jonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen M. Jonas more than expected).

Fields of papers citing papers by Maureen M. Jonas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen M. Jonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen M. Jonas. The network helps show where Maureen M. Jonas may publish in the future.

Co-authorship network of co-authors of Maureen M. Jonas

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen M. Jonas. A scholar is included among the top collaborators of Maureen M. Jonas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen M. Jonas. Maureen M. Jonas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Indolfi, Giuseppe, Regino P. González‐Peralta, Maureen M. Jonas, et al.. (2024). ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource‐limited settings. Journal of Pediatric Gastroenterology and Nutrition. 78(4). 957–972. 10 indexed citations
2.
Elisofon, Scott, Michael A. Ferguson, Maureen M. Jonas, et al.. (2023). A quality improvement intervention to decrease the decline in renal function in pediatric liver transplant recipients. Pediatric Transplantation. 27(4). e14506–e14506. 1 indexed citations
3.
Lee, Christine K., Silvia Nastasio, Paul D. Mitchell, et al.. (2020). Transient elastography assessment of liver allograft fibrosis in pediatric transplant recipients. Pediatric Transplantation. 24(6). e13736–e13736. 15 indexed citations
4.
Jonas, Maureen M., René Romero, Étienne Sokal, et al.. (2020). IDDF2020-ABS-0059 Safety and efficacy of sofosbuvir/velpatasvir (SOF/VEL) in pediatric patients 6 to < 18 years old with chronic hepatitis C (CHC) infection. Abstracts. A74.1–A74. 7 indexed citations
5.
Terrault, Norah A., Anna S. Lok, Brian J. McMahon, et al.. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 67(4). 1560–1599. 2650 indexed citations breakdown →
6.
Desai, Nirav K., Sarah Harney, Roshan Raza, et al.. (2016). Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients. The Journal of Pediatrics. 173. 160–164.e1. 99 indexed citations
7.
Jonas, Maureen M.. (2013). Hepatitis B virus infection in children. Clinical Liver Disease. 2(1). 41–44. 2 indexed citations
8.
Ramon‐Krauel, Marta, Cara B. Ebbeling, Stephan D. Voss, et al.. (2013). A Low-Glycemic-Load versus Low-Fat Diet in the Treatment of Fatty Liver in Obese Children. Childhood Obesity. 9(3). 252–260. 64 indexed citations
9.
Cauley, Ryan P., Daniel Kamin, C. Walton Lillehei, et al.. (2012). Multivisceral transplantation using a 2.9 kg neonatal donor. Pediatric Transplantation. 16(8). E379–82. 9 indexed citations
10.
Rodrigue, James R., William F. Balistreri, Barbara Haber, et al.. (2011). Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children. Hepatology. 53(5). 1468–1475. 18 indexed citations
11.
Jonas, Maureen M., Joan M. Block, Barbara Haber, et al.. (2010). Treatment of Children With Chronic Hepatitis B Virus Infection in the United States. Hepatology. 52(6). 2192–2205. 92 indexed citations
12.
Fong, Hiu‐fai, et al.. (2008). Prevalence and Predictors of Abnormal Liver Enzymes in Young Women with Anorexia Nervosa. The Journal of Pediatrics. 153(2). 247–253. 34 indexed citations
13.
Pall, Harpreet & Maureen M. Jonas. (2005). Pediatric hepatobiliary disease. Current Opinion in Gastroenterology. 21(3). 344–347. 2 indexed citations
14.
González‐Peralta, Regino P., Déirdre Kelly, Barbara Haber, et al.. (2005). Interferon Alfa-2b in Combination With Ribavirin for the Treatment of Chronic Hepatitis C in Children: Efficacy, Safety, and Pharmacokinetics *. Hepatology. 42(5). 1010–1018. 85 indexed citations
15.
Chang, Mei‐Hwei, et al.. (2004). Acute and Chronic Hepatitis: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology and Nutrition. 39. S584–S588. 11 indexed citations
16.
Jonas, Maureen M., J. Mizerski, Isabel Badía, et al.. (2002). Clinical Trial of Lamivudine in Children with Chronic Hepatitis B. New England Journal of Medicine. 346(22). 1706–1713. 197 indexed citations
17.
Laor, Tal, Fredric A. Hoffer, Joseph P. Vacanti, & Maureen M. Jonas. (1998). MR cholangiography in children after liver transplantation from living related donors.. American Journal of Roentgenology. 170(3). 683–687. 18 indexed citations
18.
Jonas, Maureen M.. (1995). Hereditary Hemorrhagic Telangiectasia. Journal of Pediatric Gastroenterology and Nutrition. 20(2). 238–238. 17 indexed citations
19.
Pérez‐Atayde, Antonio R., et al.. (1994). Hereditary Hemorrhagic Telangiectasia Presenting in Early Childhood. Journal of Pediatric Gastroenterology and Nutrition. 18(4). 497–500.
20.
Jonas, Maureen M. & Margaret Eidson. (1988). Propylthiouracil Hepatotoxicity. Journal of Pediatric Gastroenterology and Nutrition. 7(5). 776–779. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026